Katana Labs, established in April 2023 in Germany, offers a cutting-edge cloud- and AI-based image analysis pipeline for cancer diagnostics, targeting clinical pathology and biotech R&D workflows. The company’s flagship product, PAIKON, is an AI-powered, cloud-based platform designed to revolutionize cancer diagnostics with advanced image analysis software, featuring a browser-based graphical user interface. Leveraging the expertise of experts in image analysis and deep learning, Katana Labs focuses to significantly reduce pathologists’ analysis time.

Management

Nicolaus Widera
COO
Linkedin

Walter de Back, PhD
CTO
Linkedin

Falk Zakrzewski, PhD
CEO
Linkedin

Advisors

Prof. Martin Weigert, PhD
Lead Scientific Advisor
Google Scholar

Associate Prof. Ulrich Sommer, MD
Lead Medical Advisor
Linkedin